D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats

Long-term occupancy of dopamine D 2 -receptors, as achieved by chronic treatment with antipsychotics, leads to D 2 -receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychopharmacology (New York, N.Y.) N.Y.), 2009-02, Vol.34 (3), p.662-671
Hauptverfasser: Ginovart, Nathalie, Wilson, Alan A, Hussey, Doug, Houle, Sylvain, Kapur, Shitij
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 671
container_issue 3
container_start_page 662
container_title Neuropsychopharmacology (New York, N.Y.)
container_volume 34
creator Ginovart, Nathalie
Wilson, Alan A
Hussey, Doug
Houle, Sylvain
Kapur, Shitij
description Long-term occupancy of dopamine D 2 -receptors, as achieved by chronic treatment with antipsychotics, leads to D 2 -receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D 2 -receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60 vs >80%) and durations (a transient peak vs 24 h/day) of D 2 -receptor blockade on inducing this upregulation. These different patterns of D 2 -receptor occupancy kinetics were produced in cats using bolus vs constant infusion of haloperidol for 4 weeks. D 2 -receptors were measured using positron emission tomography and Scatchard analyses of [ 11 C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D 2 -receptor blockade led to a robust upregulation of striatal D 2 -receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D 2 -receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D 2 -receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D 2 -receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D 2 -receptor blockade but also on the daily duration of D 2 -receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.
doi_str_mv 10.1038/npp.2008.116
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66807771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1625226691</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1196-ccd23c2fbe898c48959e08f772ada615a74e5f8c0218da7adeecf0a560ac17583</originalsourceid><addsrcrecordid>eNpdkcFLHDEUxoO06Hb11nMJPfQ2a16yk2R6k9GqsLBFVxCkhJh5s4zMJnEyc9iD_3sjWgqeHrz3ex9830fIV2ALYEKf-hgXnDG9AJAHZAZqyQoplvefyIzpShQgxP0R-ZLSE2NQKqkPyRFoqTUHNiMv57y4QYdxDAO9iwNup96OXfC0S_QcI_oG_UinmDcb3MUw2J7WYRoS0tDS_L12borWu_1PekZXwW-7cWo6n7EHgPpPcWNdH-LQNUh_X2zobb7uaedpbcd0TD63tk948j7n5O7Xxaa-Klbry-v6bFVEgEoWzjVcON4-oq60W-qqrJDpViluGyuhtGqJZasd46Abq2yD6FpmS8msA1VqMSc_3nTjEJ4nTKPZdclh31uPYUpGSs2UUpDB7x_Ap-w1m0mG85IzkdPN0Ld3aHrcYWOyuZ0d9uZfqhko3oCUT36Lw38VYOa1NZNbM6-tmdya-Avuk4eh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225203740</pqid></control><display><type>article</type><title>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ginovart, Nathalie ; Wilson, Alan A ; Hussey, Doug ; Houle, Sylvain ; Kapur, Shitij</creator><creatorcontrib>Ginovart, Nathalie ; Wilson, Alan A ; Hussey, Doug ; Houle, Sylvain ; Kapur, Shitij</creatorcontrib><description>Long-term occupancy of dopamine D 2 -receptors, as achieved by chronic treatment with antipsychotics, leads to D 2 -receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D 2 -receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60 vs &gt;80%) and durations (a transient peak vs 24 h/day) of D 2 -receptor blockade on inducing this upregulation. These different patterns of D 2 -receptor occupancy kinetics were produced in cats using bolus vs constant infusion of haloperidol for 4 weeks. D 2 -receptors were measured using positron emission tomography and Scatchard analyses of [ 11 C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D 2 -receptor blockade led to a robust upregulation of striatal D 2 -receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D 2 -receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D 2 -receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D 2 -receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D 2 -receptor blockade but also on the daily duration of D 2 -receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/npp.2008.116</identifier><identifier>PMID: 18688210</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Animals ; Antipsychotics ; Behavioral Sciences ; Biological Psychology ; Cats ; Corpus Striatum - diagnostic imaging ; Corpus Striatum - drug effects ; Dopamine ; Dopamine D2 Receptor Antagonists ; Dose-Response Relationship, Drug ; Drug dosages ; Drug Tolerance ; Drug withdrawal ; Dyskinesia ; Haloperidol - administration &amp; dosage ; Haloperidol - pharmacology ; Longitudinal Studies ; Medicine ; Medicine &amp; Public Health ; Motor Activity - drug effects ; Neurosciences ; original-article ; Pharmacotherapy ; Positron-Emission Tomography ; Psychiatry ; Psychotropic drugs ; Raclopride - metabolism ; Receptors, Dopamine D2 - metabolism ; Tomography ; Up-Regulation - drug effects</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2009-02, Vol.34 (3), p.662-671</ispartof><rights>American College of Neuropsychopharmacology 2009</rights><rights>Copyright Nature Publishing Group Feb 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/npp.2008.116$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/npp.2008.116$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18688210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ginovart, Nathalie</creatorcontrib><creatorcontrib>Wilson, Alan A</creatorcontrib><creatorcontrib>Hussey, Doug</creatorcontrib><creatorcontrib>Houle, Sylvain</creatorcontrib><creatorcontrib>Kapur, Shitij</creatorcontrib><title>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacol</addtitle><addtitle>Neuropsychopharmacology</addtitle><description>Long-term occupancy of dopamine D 2 -receptors, as achieved by chronic treatment with antipsychotics, leads to D 2 -receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D 2 -receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60 vs &gt;80%) and durations (a transient peak vs 24 h/day) of D 2 -receptor blockade on inducing this upregulation. These different patterns of D 2 -receptor occupancy kinetics were produced in cats using bolus vs constant infusion of haloperidol for 4 weeks. D 2 -receptors were measured using positron emission tomography and Scatchard analyses of [ 11 C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D 2 -receptor blockade led to a robust upregulation of striatal D 2 -receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D 2 -receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D 2 -receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D 2 -receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D 2 -receptor blockade but also on the daily duration of D 2 -receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.</description><subject>Animals</subject><subject>Antipsychotics</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Cats</subject><subject>Corpus Striatum - diagnostic imaging</subject><subject>Corpus Striatum - drug effects</subject><subject>Dopamine</subject><subject>Dopamine D2 Receptor Antagonists</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug dosages</subject><subject>Drug Tolerance</subject><subject>Drug withdrawal</subject><subject>Dyskinesia</subject><subject>Haloperidol - administration &amp; dosage</subject><subject>Haloperidol - pharmacology</subject><subject>Longitudinal Studies</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Motor Activity - drug effects</subject><subject>Neurosciences</subject><subject>original-article</subject><subject>Pharmacotherapy</subject><subject>Positron-Emission Tomography</subject><subject>Psychiatry</subject><subject>Psychotropic drugs</subject><subject>Raclopride - metabolism</subject><subject>Receptors, Dopamine D2 - metabolism</subject><subject>Tomography</subject><subject>Up-Regulation - drug effects</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkcFLHDEUxoO06Hb11nMJPfQ2a16yk2R6k9GqsLBFVxCkhJh5s4zMJnEyc9iD_3sjWgqeHrz3ex9830fIV2ALYEKf-hgXnDG9AJAHZAZqyQoplvefyIzpShQgxP0R-ZLSE2NQKqkPyRFoqTUHNiMv57y4QYdxDAO9iwNup96OXfC0S_QcI_oG_UinmDcb3MUw2J7WYRoS0tDS_L12borWu_1PekZXwW-7cWo6n7EHgPpPcWNdH-LQNUh_X2zobb7uaedpbcd0TD63tk948j7n5O7Xxaa-Klbry-v6bFVEgEoWzjVcON4-oq60W-qqrJDpViluGyuhtGqJZasd46Abq2yD6FpmS8msA1VqMSc_3nTjEJ4nTKPZdclh31uPYUpGSs2UUpDB7x_Ap-w1m0mG85IzkdPN0Ld3aHrcYWOyuZ0d9uZfqhko3oCUT36Lw38VYOa1NZNbM6-tmdya-Avuk4eh</recordid><startdate>200902</startdate><enddate>200902</enddate><creator>Ginovart, Nathalie</creator><creator>Wilson, Alan A</creator><creator>Hussey, Doug</creator><creator>Houle, Sylvain</creator><creator>Kapur, Shitij</creator><general>Springer International Publishing</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200902</creationdate><title>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</title><author>Ginovart, Nathalie ; Wilson, Alan A ; Hussey, Doug ; Houle, Sylvain ; Kapur, Shitij</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1196-ccd23c2fbe898c48959e08f772ada615a74e5f8c0218da7adeecf0a560ac17583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antipsychotics</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Cats</topic><topic>Corpus Striatum - diagnostic imaging</topic><topic>Corpus Striatum - drug effects</topic><topic>Dopamine</topic><topic>Dopamine D2 Receptor Antagonists</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug dosages</topic><topic>Drug Tolerance</topic><topic>Drug withdrawal</topic><topic>Dyskinesia</topic><topic>Haloperidol - administration &amp; dosage</topic><topic>Haloperidol - pharmacology</topic><topic>Longitudinal Studies</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Motor Activity - drug effects</topic><topic>Neurosciences</topic><topic>original-article</topic><topic>Pharmacotherapy</topic><topic>Positron-Emission Tomography</topic><topic>Psychiatry</topic><topic>Psychotropic drugs</topic><topic>Raclopride - metabolism</topic><topic>Receptors, Dopamine D2 - metabolism</topic><topic>Tomography</topic><topic>Up-Regulation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ginovart, Nathalie</creatorcontrib><creatorcontrib>Wilson, Alan A</creatorcontrib><creatorcontrib>Hussey, Doug</creatorcontrib><creatorcontrib>Houle, Sylvain</creatorcontrib><creatorcontrib>Kapur, Shitij</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ginovart, Nathalie</au><au>Wilson, Alan A</au><au>Hussey, Doug</au><au>Houle, Sylvain</au><au>Kapur, Shitij</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><stitle>Neuropsychopharmacol</stitle><addtitle>Neuropsychopharmacology</addtitle><date>2009-02</date><risdate>2009</risdate><volume>34</volume><issue>3</issue><spage>662</spage><epage>671</epage><pages>662-671</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><abstract>Long-term occupancy of dopamine D 2 -receptors, as achieved by chronic treatment with antipsychotics, leads to D 2 -receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D 2 -receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60 vs &gt;80%) and durations (a transient peak vs 24 h/day) of D 2 -receptor blockade on inducing this upregulation. These different patterns of D 2 -receptor occupancy kinetics were produced in cats using bolus vs constant infusion of haloperidol for 4 weeks. D 2 -receptors were measured using positron emission tomography and Scatchard analyses of [ 11 C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D 2 -receptor blockade led to a robust upregulation of striatal D 2 -receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D 2 -receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D 2 -receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D 2 -receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D 2 -receptor blockade but also on the daily duration of D 2 -receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>18688210</pmid><doi>10.1038/npp.2008.116</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0893-133X
ispartof Neuropsychopharmacology (New York, N.Y.), 2009-02, Vol.34 (3), p.662-671
issn 0893-133X
1740-634X
language eng
recordid cdi_proquest_miscellaneous_66807771
source MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Antipsychotics
Behavioral Sciences
Biological Psychology
Cats
Corpus Striatum - diagnostic imaging
Corpus Striatum - drug effects
Dopamine
Dopamine D2 Receptor Antagonists
Dose-Response Relationship, Drug
Drug dosages
Drug Tolerance
Drug withdrawal
Dyskinesia
Haloperidol - administration & dosage
Haloperidol - pharmacology
Longitudinal Studies
Medicine
Medicine & Public Health
Motor Activity - drug effects
Neurosciences
original-article
Pharmacotherapy
Positron-Emission Tomography
Psychiatry
Psychotropic drugs
Raclopride - metabolism
Receptors, Dopamine D2 - metabolism
Tomography
Up-Regulation - drug effects
title D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A22%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=D2-Receptor%20Upregulation%20is%20Dependent%20upon%20Temporal%20Course%20of%20D2-Occupancy:%20A%20Longitudinal%20%5B11C%5D-Raclopride%20PET%20Study%20in%20Cats&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Ginovart,%20Nathalie&rft.date=2009-02&rft.volume=34&rft.issue=3&rft.spage=662&rft.epage=671&rft.pages=662-671&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/10.1038/npp.2008.116&rft_dat=%3Cproquest_pubme%3E1625226691%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=225203740&rft_id=info:pmid/18688210&rfr_iscdi=true